Novo Integrated Sciences Cost of Goods Sold 2012-2024 | NVOS

Novo Integrated Sciences cost of goods sold from 2012 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Novo Integrated Sciences Annual Cost of Goods Sold
(Millions of US $)
2023 $8
2022 $7
2021 $5
2020 $5
2019 $6
2018 $5
2017 $5
2016 $
2016 $5
2015 $
2014 $
2013 $
2012 $
2012 $
2011 $
2011 $
Novo Integrated Sciences Quarterly Cost of Goods Sold
(Millions of US $)
2024-05-31 $2
2024-02-29 $2
2023-11-30 $2
2023-08-31 $2
2023-05-31 $2
2023-02-28 $2
2022-11-30 $2
2022-08-31 $-8
2022-05-31 $11
2022-02-28 $2
2021-11-30 $2
2021-08-31 $2
2021-05-31 $1
2021-02-28 $1
2020-11-30 $1
2020-08-31 $1
2020-05-31 $1
2020-02-29 $2
2019-11-30 $2
2019-08-31 $2
2019-05-31 $2
2019-02-28 $1
2018-11-30 $1
2018-08-31 $1
2018-05-31 $1
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $1
2017-03-31
2017-02-28 $1
2016-12-31
2016-11-30 $1
2016-09-30
2016-06-30
2016-05-31 $1
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.006B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00